Header

UZH-Logo

Maintenance Infos

Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter - still a dilemma?


Hegi, Monika E; Stupp, Roger (2015). Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter - still a dilemma? Neuro-Oncology, 17(11):1425-1427.

Statistics

Citations

Dimensions.ai Metrics
58 citations in Web of Science®
60 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

39 downloads since deposited on 04 Feb 2016
10 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology and Hematology
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Oncology
Health Sciences > Neurology (clinical)
Life Sciences > Cancer Research
Language:English
Date:November 2015
Deposited On:04 Feb 2016 09:31
Last Modified:26 Jan 2022 08:25
Publisher:Oxford University Press
ISSN:1522-8517
OA Status:Hybrid
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.1093/neuonc/nov198
PubMed ID:26374690
  • Content: Published Version
  • Language: English
  • Description: Nationallizenz 142-005
  • Content: Published Version
  • Language: English
  • Description: Nationallizenz 142-005